Abstract
Congenital toxoplasmosis is a potentially devastating congenital infection caused by Toxoplasma gondii. Pregnant women may acquire primary infection after exposure to cat feces, by ingestion of oocysts on unwashed fruits and vegetables, or by ingestion of bradyzoites in raw or undercooked meat. Infection in pregnant women is usually subclinical or mild; in the absence of screening programs, the diagnosis is rarely made clinically. Fetal infection can result in hydrocephalus, intracerebral calcifications, and chorioretinitis; however, like most congenital infections, the majority of infants with congenital toxoplasmosis are asymptomatic in the newborn period. Treatment of infected infants with combination antiparasitic therapy for 1 year can dramatically improve clinical outcomes. The primary long-term morbidity of congenital toxoplasmosis includes ocular reactivations and central nervous system injury. Prevention of congenital toxoplasmosis is based on education of exposure risks and antiparasitic therapy during pregnancy if infection is identified.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis, and treatment. Expert Rev Anti-Infect Ther. 2012;10:815–28.
Tamma P. Toxoplasmosis. Pediatr Rev. 2007;28:470–1.
Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39:1385–94.
Jones JL, Kruszon-Moran D, Rivera HN, Price C, Wilkins PP. Toxoplasma gondii seroprevalence in the United States 2009–2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014;90:1135–9.
Roberts T, Frenkel JK. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. JAMA. 1990;2:249–56.
Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–8.
Dubey JP, Bhatia CR, Lappin MR, Ferreira LR, Thorn A, Kwok OC. Seroprevalence of Toxoplasma gondii and Bartonella spp. Antibodies in cats from Pennsylvania. J Parasitol. 2009;95:578–80.
Boyer KM, Holfels E, Roizen N, et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol. 2005;192:564–71.
Mahmoudvand H, Saedi Dezaki E, Soleimani S, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran. Parasite Immunol. 2015;37(7):362.
Bachmeyer C, Mouchnino G, Thulliez P, Blum L. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation. J Infect. 2006;52:e55–7.
Campos FA, Andrade GM, Lanna Ade P, et al. Incidence of congenital toxoplasmosis among infants born to HIV-coinfected mothers: case series and literature review. Braz J Infect Dis. 2014;18:609–17.
Kodjikian L, Hoigne I, Adam O, et al. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatr Infect Dis J. 2004;23:272–4.
Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet. 1999;353:1829–33.
Desmonts G, Couvreur J. Congenital toxoplasmosis—a prospective study of 378 pregnancies. N Engl J Med. 1974;290:1110–6.
Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis. 2012;44:805–14.
Contini C. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parassitologia. 2008;50:45–50.
Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Inf Dis J. 2011;30:1056–61.
McLeod R, Boyer K, Karrison T, et al. Outcome of treatment for congenital toxoplasmosis, 1981–2004: the national collaborative Chicago-based, congenital toxoplasmosis study. Clin Inf Dis. 2006;42:1383–94.
Eichenwald HF. A study of congenital toxoplasmosis, with particular emphasis on clinical manifestations, sequelae, and therapy. In: Siim JC, editor. Human toxoplasmosis. Copenhagen: Munksgaard; 1960. p. 41–9.
Peyron F, Wallon M, Kieffer F, Garweg J. Toxoplasmosis. In: Wilson CB, Nizet V, Maldonado YA, Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 8th ed. Philadelphia, PA: Elsevier; 2016. p. 949–1042.
Arun V, Noble AG, Latkany P, et al. Cataracts in congenital toxoplasmosis. J AAPOS. 2007;11:551–4.
Pomares C, Montoya JG. Laboratory diagnosis of congenital toxoplasmosis. J Clin Microbiol. 2016;54:2448–54.
Rostami A, Karanis P, Fallahi S. Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection. Infection. Available online Jan. 2018;12:2018.
U.S. Department of Health and Human Services. Aidsinfo: Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-opportunistic-infection/322/toxo. Accessed 17 Feb 2018.
Robert-Gangneux F, Brenier-Pinchart MP, Yera H, et al. Evaluation of toxoplasma ELITe MGB real-time PCR assay for diagnosis of toxoplasmosis. J Clin Microbiol. 2017;55:1369–76.
Gilbert RE, Thalib L, Tan HK, et al. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen. 2007;14:8–13.
Olariu TR, Remington JS, Montoya JG. Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2014;33:566–70.
Filisetti D, Cocquerelle V, Pfaff A, Villard O, Candolfi E. Placental testing for Toxoplasma gondii is not useful to diagnose congenital toxoplasmosis. Pediatr Infect Dis J. 2010;29:671–2.
Avci ME, Arslan F, Ciftci S, et al. Role of spiramycin in prevention of fetal toxoplasmosis. J Matern Fetal Neonatal Med. 2016;29:2073–6.
Chaudhry SA, Gad N, Koren G. Toxoplasmosis and pregnancy. Can Fam Physician. 2014;60:334–6.
Jeon J, Victor M, Adler SP, et al. Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol. 2006;2006:80383.
Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy—an epidemiologic survey over 22 consecutive years. J Perinat Med. 2004;32:211–4.
Di Mario S, Basevi V, Gagliotti C, et al. Prenatal education for congenital toxoplasmosis. Cochrane Database Syst Rev. 2015;23:CD006171.
Thiebaut R, Leproust S, Chene G, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007;369:115–22.
American College of Obstetricians and Gynecologists. Practice bulletin no. 151: cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol. 2015;125:1510–25.
Maldonado YA, Read JS, Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139:e20163860.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ballard, A.R. (2018). Toxoplasmosis. In: Cantey, J. (eds) Neonatal Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-90038-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-90038-4_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90037-7
Online ISBN: 978-3-319-90038-4
eBook Packages: MedicineMedicine (R0)